BROYDRICK & ASSOCIATES

Lobbying for TONIX PHARMACEUTICALS · Pharmaceutical development and manufacturing.

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Oct 20, 2025.

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Government bodies contacted 3

Defense, Dept of (DOD)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Pharmacy

Funding new drug for PTSD and COVID 19, BARDA appropriations.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.